ArticleThe Journal of pharmacology and experimental therapeutics2019

Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.

Shane W Kaski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.